182 related articles for article (PubMed ID: 7531282)
1. Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone.
van der Linden C; Bruggeman R; van Woerkom TC
Mov Disord; 1994 Nov; 9(6):687-8. PubMed ID: 7531282
[No Abstract] [Full Text] [Related]
2. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
[TBL] [Abstract][Full Text] [Related]
3. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
Fowler JA; Bettinger TL; Argo TR
Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profile of risperidone.
Ereshefsky L; Lacombe S
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S80-8. PubMed ID: 7504573
[TBL] [Abstract][Full Text] [Related]
5. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.
Czobor P; Volavka J
J Clin Psychopharmacol; 1993 Oct; 13(5):332-42. PubMed ID: 7693770
[TBL] [Abstract][Full Text] [Related]
6. Pavor nocturnus as a side effect of a single daily risperidone dose.
Prueter C; Luecke FG; Hoff P
Gen Hosp Psychiatry; 2005; 27(4):300-1. PubMed ID: 15993264
[No Abstract] [Full Text] [Related]
7. Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug.
Keegan D
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S46-52. PubMed ID: 7533051
[TBL] [Abstract][Full Text] [Related]
8. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
Kopala LC; Honer WG
J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
[No Abstract] [Full Text] [Related]
9. Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial.
Goetz CG; Stebbins GT; Thelen JA
Mov Disord; 1994 May; 9(3):315-7. PubMed ID: 7913738
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic medication in the treatment of schizophrenia.
Kane JM
Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
[TBL] [Abstract][Full Text] [Related]
11. [Malignant neuroleptic syndrome associated to risperidone].
Aguirre C; García Monco JC; Mendibil B
Med Clin (Barc); 1998 Feb; 110(6):239. PubMed ID: 9547739
[No Abstract] [Full Text] [Related]
12. Iloperidone for schizophrenia.
Rado J; Janicak PG
Expert Opin Pharmacother; 2010 Aug; 11(12):2087-93. PubMed ID: 20586713
[TBL] [Abstract][Full Text] [Related]
13. [Nicotine and Tourette's syndrome].
Erdmann R; Schneider U
Psychiatr Prax; 1996 Jan; 23(1):41-2. PubMed ID: 8851234
[No Abstract] [Full Text] [Related]
14. Neuroleptic malignant syndrome with risperidone.
Gleason PP; Conigliaro RL
Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
[TBL] [Abstract][Full Text] [Related]
15. Iloperidone for the management of adults with schizophrenia.
Crabtree BL; Montgomery J
Clin Ther; 2011 Mar; 33(3):330-45. PubMed ID: 21600386
[TBL] [Abstract][Full Text] [Related]
16. Risperidone in Gilles de la Tourette syndrome.
Shulman LM; Singer C; Weiner WJ
Neurology; 1995 Jul; 45(7):1419. PubMed ID: 7542376
[No Abstract] [Full Text] [Related]
17. Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
Dickson R; Williams R; Dalby JT
Can J Psychiatry; 1994 Apr; 39(3):184. PubMed ID: 7518338
[No Abstract] [Full Text] [Related]
18. Risperidone as a treatment for Tourette's syndrome.
Bruun RD; Budman CL
J Clin Psychiatry; 1996 Jan; 57(1):29-31. PubMed ID: 8543544
[TBL] [Abstract][Full Text] [Related]
19. Guanfacine for Tourette's disorder.
Fras I
J Am Acad Child Adolesc Psychiatry; 1996 Jan; 35(1):3-4. PubMed ID: 8567607
[No Abstract] [Full Text] [Related]
20. Cautions in the clozapine-to-risperidone switch.
Gupta S; Daniel DG
Ann Clin Psychiatry; 1995 Sep; 7(3):149. PubMed ID: 8646276
[No Abstract] [Full Text] [Related]
[Next] [New Search]
